Skip to content
healthcare.dev

METFORMIN HYDROCHLORIDE

NDC 68180-338, METFORMIN HYDROCHLORIDE, tablet, extended release, from Lupin Pharmaceuticals, Inc..

Product NDC
68180-338
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091664
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68180-338 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METFORMIN HYDROCHLORIDE500 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]

Package NDCNDC-11Package
68180-338-0168180033801100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-338-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1200ea71-8a9e-4e49-bb77-7d9fe0d84ae7
  • NADAC price for package 68180033801

    GET /v1/drugs/nadac/68180033801

Use it

Look up 68180-338 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68180-338 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68180-338. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.